Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
2.790
-0.040 (-1.41%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Puma Biotechnology Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Puma Biotechnology stock has a target of 7.00, which predicts an increase of 150.90% from the current stock price of 2.79.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $7.00 $7.00 $7.00 $7.00
Change +150.90% +150.90% +150.90% +150.90%
* Price targets were last updated on Aug 2, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for PBYI is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 111111
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +150.90% Aug 2, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +150.90% Jul 26, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +150.90% Jun 4, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +150.90% Jun 3, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +150.90% May 20, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
222.33M
from 235.64M
Decreased by -5.65%
Revenue Next Year
211.85M
from 222.33M
Decreased by -4.71%
EPS This Year
0.26
from 0.45
Decreased by -41.29%
EPS Next Year
0.20
from 0.26
Decreased by -23.68%
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
272.26M225.11M253.16M228.03M235.64M222.33M211.85M209.41M
Revenue Growth
8.47%-17.32%12.46%-9.92%3.34%-5.65%-4.71%-1.15%
EPS
-1.95-1.52-0.720.000.450.260.200.21
EPS Growth
----1,022,625.00%-41.29%-23.68%4.55%
Forward PE
-----10.5613.8413.24
No. Analysts -----555
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 231.0M 238.5M 253.0M
Avg 222.3M 211.9M 209.4M
Low 211.6M 182.3M 166.6M

Revenue Growth

Revenue Growth 20242025202620272028
High
-2.0%
7.3%
19.4%
Avg
-5.6%
-4.7%
-1.2%
Low
-10.2%
-18.0%
-21.4%

EPS Forecast

EPS 20242025202620272028
High 0.29 0.59 0.85
Avg 0.26 0.20 0.21
Low 0.25 -0.05 -0.25

EPS Growth

EPS Growth 20242025202620272028
High
-35.4%
122.6%
321.8%
Avg
-41.3%
-23.7%
4.6%
Low
-45.6%
- -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.